Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 154

Legend Capital stirs Mathpresso to series B

The SoftBank, Samsung and Megastudy-backed maths tutoring app developer secured $14.5m in a round led by Legend Capital.

Oct 16, 2019

Ansun gets its hands on $80m

Lilly Asia Ventures returned for the respiratory disease drug developer's series B round, having co-led its $85m series A last year.

Oct 15, 2019

EWTP Fund makes XTransfer in $15m round

The Alibaba-backed ETWP Fund led a series B-1 round for XTransfer, which will put the cash towards expanding its cross-border financial services.

Oct 15, 2019

Parsley Health packs in $26m

The Chernin Group-backed personalised care provider plans to use the series B funding to expand into new cities and take its telemedicine offering nationwide.

Oct 14, 2019

Citrine formulates $20m series B

Advanced materials and chemicals platform developer Citrine Informatics has now received about $44m in total, having secured Siemens Next47 as an investor.

Oct 14, 2019

Corporate venturing deal net: 7-11 October 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Oct 11, 2019

Osaro picks up $16m

The factory robotics software provider has now raised more than $29m altogether, with iRobot and Comcast likely among the investors in its series B round.

Oct 10, 2019

RapidSOS wraps up $55m series B

Emergency response support platform RapidSOS added $25m to close a series B round that already featured CSAA and Microsoft's M12 unit.

Oct 9, 2019

Tier ties Axa to $60m round

The scooter rental platform has now raised more than $95m altogether, after Axa Germany participated in a series B round that will fund European growth.

Oct 8, 2019

Arcellx arranges $85m series B

LG Technology Ventures and existing investors Novo, SR One and Takeda Ventures all took part in a round that will support the advance of Arcellx's immuno-oncology cell therapies.

Oct 8, 2019

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here